Skip to main content
. 2024 Mar 23;27(2):355–362. doi: 10.1007/s40477-024-00874-z

Table 3.

Echocardiographic findings according to ESC risk class

Esc class
Low, N = 134, 26.3% Intermediate-low, N = 220, 43.2% Intermediate, N = 57, 11.2% Intermediate-high, N = 84, 16.5% High, N = 14, 2.8% p value
RV > LV 0 (0) 26 (11.8) 33 (57.8) 49 (58.3) 10 (71.4)  < 0.001
D-shape 0 (0) 7 (3.2) 13 (22.8) 33 (39.3) 6 (42.8)  < 0.001
TAPSE in mm 23 (20–25) 20 (18–24) 20 (16–22) 16 (14–20) 15 (13–21)  < 0.001
TAPSE < 21 mm 50 (37.3) 111 (50.5) 37 (64.9) 58 (69) 9 (64.2)  < 0.001
TAPSE < 16 mm 0 (0) 11 (5) 15 (26.3) 39 (46.4) 5 (35.7)  < 0.001
sPAP mmhg mm 30 (25–35) 35 (26–45) 45 (30–51) 50 (35–60) 50 (40–60)  < 0.001
sPAP > 40 mmHg 13 (9.7) 59 (26.8) 35 (61.4) 38 (45.2) 9 (64.2)  < 0.001
sPAP > 60 mmHg 0 (0) 8 (3.6) 9 (15.8) 17 (20.2) 3 (21.4)  < 0.001
LVEF% 60 (60–64) 60 (57–63) 60 (56–63) 60 (55–60) 55 (36–64) 0.006
LVEF 35–55% 9 (6.7) 35 (15.9) 7 (12.3) 15 (17.9) 2 (14.2) 0.063
LVEF < 35% 2 (1.5) 6 (2.7) 1 (1.8) 2 (2.4) 3 (21.4) 0.001

IVC

collapsibility < 50%

56 (41.7) 66 (30) 21 (36.8) 42 (50) 5 (35.7) 0.065
abnormal hs-cTnI levels 0 (0) 36 (16.4) 41 (71.9) 83 (98.8) 11 (78.6)  < 0.001
IHM 3 (2.2) 11 (5) 4 (7) 13 (15.5) 5 (35.7)  < 0.001